The Jupiter Medical Center in Florida has adopted IBM’s Watson for Oncology service, making it the first US hospital to do so.
The hospital will use the AI to aid in cancer treatment decisions based on insights gathered by Watson from clinical data in medical journals, textbooks and scientific literature.
Once Watson gathers its insights, it ranks them in order of most applicable to each specific case, helping doctors make decisions about which treatment to give their patients.
Watson’s machine learning feature means that its ability to provide the most up-to-date and accurate clinical data insights improves over time.
“We were impressed by Watson’s analytical ability to help provide relevant treatment options for patients to allow physicians to personalise patient care in an unparalleled way,” said Abraham Schwarzberg, chief of Oncology at Jupiter Medical Center. “Harnessing the power of Watson will help our oncology multidisciplinary team identify individual treatments.”
Watson for Oncology was originally developed in partnership with Memorial Sloan Kettering (MSK) with the intention to create a platform capable of improving current cancer care decisions.
In its current form, the AI service can aid in the development of treatment regimens for breast, lung, colorectal, cervical, ovarian and gastric cancers. Both IBM and MSK are looking to train Watson to assist in clinical decisions for a further nine cancers by the end of the year, meaning it will be able to cover around 80% of the worldwide incidence of cancer.
The deal continues a busy week for IBM Watson Health which only recently launched a crowdsourcing project to aid in childhood cancer research.